Energenesis Biomedical Co Ltd Stock Forecast - Energenesis Biomedical Co Ltd

E	Energenesis Biomedical Co Ltd TWSE:6657	TW
	WPP PLC LSE:WPP	UK
	BioNTech SE NASDAQ:BNTX	DE
	UniCredit SpA MIL:UCG	IT
	Magic Software Enterprises Ltd NASDAQ:MGIC	IL
L	Lineage Cell Therapeutics Inc TASE:LCTX	US
K	Kimberly-Clark Corp LSE:0JQZ	US
I	Insplorion AB STO:INSP	SE
E	Empresa Distribuidora y Comercializadora Norte SA BCBA:EDN	AR
N	Nextera Energy Inc DUS:FP3	US
	ASR Nederland NV OTC:ASRRF	NL
M	Mycronic AB (publ) OTC:MICLD	SE
	Domino's Pizza Inc NASDAQ:DPZ	US
C	Christian Dior SE LSE:0NPL	FR
	Oji Holdings Corp OTC:OJIPY	JP
M	Mission Ready Solutions Inc XTSX:MRS	CA
M	Mitsubishi UFJ Financial Group Inc SWB:MFZA	JP
	Steadfast Group Ltd ASX:SDF	AU
U	US Foods Holding Corp XBER:UFH	US

Wall St Price Targets

Wall Street analysts forecast Energenesis Biomedical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Energenesis Biomedical Co Ltd is 43.86 TWD with a low forecast of 43.43 TWD and a high forecast of 45.15 TWD.

23% Upside

24% Upside

28% Upside

Tenable Holdings Inc

-26% Downside

Flex Ltd

30% Upside

Mori Trust Sogo Reit Inc

10% Upside

Amalgamated Bank

5% Upside

Tenable Holdings Inc

-26% Downside

Flex Ltd

30% Upside

Mori Trust Sogo Reit Inc

10% Upside

Amalgamated Bank

5% Upside

Revenue
Forecast

3% / Year

Past Growth

9% / Year

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

3% / Year

Past Growth

9% / Year

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

5% / Year

Past Growth

5% / Year

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

5% / Year

Past Growth

5% / Year

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 1 year is 5%.

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Continue Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for Energenesis Biomedical Co Ltd is 43.86 TWD with a low forecast of 43.43 TWD and a high forecast of 45.15 TWD.

Over the last 9 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 9%.

Over the last 9 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 1 year is 5%.

Back to Top

Energenesis Biomedical Co Ltd
TWSE:6657

Wall St Price Targets

Price Targets Summary
Energenesis Biomedical Co Ltd

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue Research

What is Energenesis Biomedical Co Ltd's stock price target?

Price Target
43.86 TWD

What is the Revenue forecast for Energenesis Biomedical Co Ltd?

Projected CAGR
9%

What is the Gross Profit forecast for Energenesis Biomedical Co Ltd?

Projected CAGR
5%

Company

Help

Tools

Stocks

Energenesis Biomedical Co Ltd TWSE:6657

Wall St Price Targets

Price Targets Summary Energenesis Biomedical Co Ltd

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue Research

What is Energenesis Biomedical Co Ltd's stock price target? Price Target 43.86 TWD

What is the Revenue forecast for Energenesis Biomedical Co Ltd? Projected CAGR 9%

What is the Gross Profit forecast for Energenesis Biomedical Co Ltd? Projected CAGR 5%

Company

Help

Tools

Stocks

Energenesis Biomedical Co Ltd
TWSE:6657

Price Targets Summary
Energenesis Biomedical Co Ltd

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is Energenesis Biomedical Co Ltd's stock price target?

Price Target
43.86 TWD

What is the Revenue forecast for Energenesis Biomedical Co Ltd?

Projected CAGR
9%

What is the Gross Profit forecast for Energenesis Biomedical Co Ltd?

Projected CAGR
5%